Selam Ogbagabriel

Securin is overexpressed in breast cancer

Selam Ogbagabriel, Manory Fernando, Frederic M. Waldman et al. · Modern Pathology · 2005 · 48 citations · Full text

Tumor Biology, Breast Oncology, Medicine +5

Tumor penetration and epidermal growth factor receptor saturation by panitumumab correlate with antitumor activity in a preclinical model of human cancer

Daniel J. Freeman, Kevin S. McDorman, Selam Ogbagabriel et al. · Molecular Cancer · 2012 · 31 citations · Full text

Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptor

Daniel J. Freeman, Tammy L. Bush, Selam Ogbagabriel et al. · Molecular Cancer Therapeutics · 2009 · 27 citations

Frequency of S492R Mutations in the Epidermal Growth Factor Receptor: Analysis of Plasma Dna from Metastatic Colorectal Cancer Patients Treated with Panitumumab or Cetuximab Monotherapy

Kathryn J. Newhall, Timothy Price, Marc Peeters et al. · Annals of Oncology · 2014 · 23 citations · Full text

Plasma Dna, Medicine, Immunology +10

Panitumumab and cetuximab epitope mapping and in vitro activity

Dan Freeman, Jing Sun, R T Bass et al. · Journal of Clinical Oncology · 2008 · 22 citations